Cargando…

Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry

BACKGROUND: Barrett's oesophagus (BE) is a pre-malignant condition leading to oesophageal adenocarcinoma (OAC). Treatment of neoplasia at an early stage is desirable. Combined endoscopic mucosal resection (EMR) followed by radiofrequency ablation (RFA) is an alternative to surgery for patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haidry, R J, Butt, M A, Dunn, J M, Gupta, A, Lipman, G, Smart, H L, Bhandari, P, Smith, L, Willert, R, Fullarton, G, Di Pietro, M, Gordon, C, Penman, I, Barr, H, Patel, P, Kapoor, N, Hoare, J, Narayanasamy, R, Ang, Y, Veitch, A, Ragunath, K, Novelli, M, Lovat, L B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Oesophagus
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515987/ https://www.ncbi.nlm.nih.gov/pubmed/25539672 http://dx.doi.org/10.1136/gutjnl-2014-308501

Ejemplares similares

Monitoring the premalignant potential of Barrett's oesophagus'
por: Graham, David, et al.
Publicado: (2016)

Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett’s oesophagus
por: Leedham, S J, et al.
Publicado: (2008)

Evolution of oesophageal adenocarcinoma from metaplastic columnar epithelium without goblet cells in Barrett's oesophagus
por: Lavery, Danielle L, et al.
Publicado: (2016)

Quality of life measures in dysplastic Barrett’s oesophagus are comparable to patients with non-dysplastic Barrett’s oesophagus and do not improve after endoscopic therapy
por: Ratcliffe, Elizabeth, et al.
Publicado: (2023)

Developing patient-orientated Barrett’s oesophagus services: the role of dedicated services
por: Ratcliffe, Elizabeth, et al.
Publicado: (2022)

Comparative quantitative survey of patient experience in Barrett’s oesophagus and other gastrointestinal disorders
por: Britton, James, et al.
Publicado: (2020)

Computational modelling suggests that Barrett’s oesophagus may be the precursor of all oesophageal adenocarcinomas
por: Curtius, Kit, et al.
Publicado: (2021)

Study to investigate the prevalence of human papillomavirus in Barrett’s oesophagus using a novel screening methodology
por: White, Jonathan Richard, et al.
Publicado: (2022)

Methylation panel is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens
por: Chettouh, Hamza, et al.
Publicado: (2018)

Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett’s oesophagus and provides insights into clinical heterogeneity in reflux diagnosis
por: Ong, Jue-Sheng, et al.
Publicado: (2022)

Mutational load may predict risk of progression in patients with Barrett’s oesophagus and indefinite for dysplasia: a pilot study
por: Trindade, Arvind J, et al.
Publicado: (2019)

The stem cell organisation, and the proliferative and gene expression profile of Barrett's epithelium, replicates pyloric-type gastric glands
por: Lavery, Danielle L, et al.
Publicado: (2014)

Volumetric laser endomicroscopy features of dysplasia at the gastric cardia in Barrett’s oesophagus: results from an observational cohort study
por: Trindade, Arvind J, et al.
Publicado: (2019)

Incidence of metachronous visible lesions in patients referred for radiofrequency ablation (RFA) therapy for early Barrett's neoplasia: a single-centre experience
por: Ortiz-Fernández-Sordo, J, et al.
Publicado: (2016)

Circulating microRNAs as potential biomarkers to detect transformation of Barrett’s oesophagus to oesophageal adenocarcinoma
por: Matsuzaki, Juntaro, et al.
Publicado: (2017)

The human squamous oesophagus has widespread capacity for clonal expansion from cells at diverse stages of differentiation
por: Barbera, Mariagnese, et al.
Publicado: (2015)

Wide-area transepithelial sampling in adjunct to forceps biopsy increases the absolute detection rates of Barrett’s oesophagus and oesophageal dysplasia: a meta-analysis and systematic review
por: Suresh Kumar, Vishnu Charan, et al.
Publicado: (2020)

Reflux symptoms and oesophageal acidification in treated achalasia patients are often not reflux related
por: Ponds, Fraukje A, et al.
Publicado: (2021)

Predictors for outcome of failure of balloon dilatation in patients with achalasia
por: Alderliesten, J, et al.
Publicado: (2010)

Machine Learning Creates a Simple Endoscopic Classification System that Improves Dysplasia Detection in Barrett's Oesophagus amongst Non-expert Endoscopists
por: Sehgal, Vinay, et al.
Publicado: (2018)

Collagen type III alpha I is a gastro-oesophageal reflux disease susceptibility gene and a male risk factor for hiatus hernia
por: Åsling, B, et al.
Publicado: (2009)

Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis
por: Vicario, M, et al.
Publicado: (2010)

Radiofrequency ablation for Barrett’s oesophagus related neoplasia with the 360 Express catheter: initial experience from the United Kingdom and Ireland—preliminary results
por: Magee, Cormac G., et al.
Publicado: (2021)

A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease
por: Keywood, C, et al.
Publicado: (2009)

Management of Barrett's oesophagus
por: Mannath, Jayan, et al.
Publicado: (2009)

Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease
por: Savarino, E, et al.
Publicado: (2009)

The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis
por: Fisher, Oliver M, et al.
Publicado: (2017)

LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma
por: Li, Jiagen, et al.
Publicado: (2014)

Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis
por: Xiao, Yinglian, et al.
Publicado: (2020)

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
por: Turkington, Richard C, et al.
Publicado: (2019)

Post-transplant lymphoproliferative disorder as a cause of oesophageal ulceration and stricture: case report and literature review
por: Mukhtar, Mariam S, et al.
Publicado: (2021)

The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis
por: Furuta, Glenn T, et al.
Publicado: (2013)

Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer
por: Chong, Irene Yushing, et al.
Publicado: (2018)

Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinoma
por: Zhou, Jin, et al.
Publicado: (2022)

Use of proton pump inhibitors after antireflux surgery: a nationwide register-based follow-up study
por: Lødrup, Anders, et al.
Publicado: (2014)

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis
por: Miehlke, Stephan, et al.
Publicado: (2016)

Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas
por: Lin, De-Chen, et al.
Publicado: (2018)

IL-20 subfamily cytokines impair the oesophageal epithelial barrier by diminishing filaggrin in eosinophilic oesophagitis
por: Kaymak, Tanay, et al.
Publicado: (2023)

Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus
por: Dunn, J M, et al.
Publicado: (2011)

Role of body composition and metabolic profile in Barrett’s oesophagus and progression to cancer
por: Di Caro, Simona, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e0g5riblels0l3ndsjr7pgfjp2